Amer et al., 2025 - Google Patents
In Vitro Production of FlavonoidsAmer et al., 2025
View PDF- Document ID
- 7089536217193798153
- Author
- Amer A
- Shahin A
- Publication year
- Publication venue
- Plant Specialized Metabolites: Phytochemistry, Ecology and Biotechnology
External Links
Snippet
Plants generate flavonoids, which are minuscule molecular secondary metabolites that have various biological roles, such as anti-carcinogenic, anti-inflammatory, and antioxidant activity. It may be found in medicinal herbs, fruits, and drinks, including tea, wine, and …
- 229930003935 flavonoid 0 title abstract description 294
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ozyigit et al. | Production of secondary metabolites using tissue culture-based biotechnological applications | |
| Wawrosch et al. | Production of bioactive plant secondary metabolites through in vitro technologies—status and outlook | |
| Sharma et al. | Metabolic engineering strategies for enhancing the production of bio-active compounds from medicinal plants | |
| Jimenez-Garcia et al. | Current approaches for enhanced expression of secondary metabolites as bioactive compounds in plants for agronomic and human health purposes-A review | |
| Panche et al. | Flavonoids: an overview | |
| Khan et al. | Plant in vitro culture technologies; a promise into factories of secondary metabolites against COVID-19 | |
| Skorić et al. | Cytotoxic activity of ethanol extracts of in vitro grown Cistus creticus subsp. creticus L. on human cancer cell lines | |
| Amer | Biotechnology approaches for in vitro production of flavonoids | |
| De Filippis | Plant secondary metabolites: From molecular biology to health products | |
| Kaur et al. | Enhanced secondary metabolite production in hairy root cultures through biotic and abiotic elicitors | |
| Khalifa et al. | Influence of gamma radiation and phenylalanine on secondary metabolites in callus cultures of milk thistle (Silybum marianum L.) | |
| Castro et al. | Elicitors as a biotechnological tool for in vitro production of bioactive phenolic compounds | |
| Trémouillaux-Guiller | Hairy root culture: an alternative terpenoid expression platform | |
| Vidya et al. | An insight into in vitro strategies for bioproduction of isoflavones | |
| Amer et al. | In Vitro Production of Flavonoids | |
| Bonfill et al. | Production and genetic engineering of terpenoids production in plant cell and organ cultures | |
| Shukla et al. | Integrative approaches for enhanced secondary metabolite production | |
| D’Amelia et al. | Biosynthesis of salvia specialized metabolites and biotechnological approaches to increase their production | |
| Gutiérrez-Grijalva et al. | Flavones and flavonols: bioactivities and responses under light stress in herbs | |
| Nandini et al. | The contemporary facts towards in vitro production of the Plant-derived medicinal metabolites | |
| Sakure et al. | Biotechnological Approaches for Medicinal and Aromatic Plant-Based Products | |
| Singh et al. | Role of mutation and stresses in the production of secondary metabolite in plants | |
| Ramawat et al. | An introduction to specialized metabolites from plants, their biological and ecological roles, and biotechnological interventions to improve the production | |
| Karabulut et al. | Production of secondary metabolites from endangered and commercially important medicinal plants through cell and tissue culture technology | |
| Garg et al. | Plant tissue culture: A potential tool for the production of secondary metabolites |